Escalon Medical Corp (ESMC) stock
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026Score 10/30
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –
Escalon Medical statistics
50 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 2.41%
- 3.32%
- Shares Change (QoQ)
- 0.00%
- 0.20%
- Float
- 7M
- 37M
- Shares Held by Insiders
- 0.00%
- 10.5%
MarginsIndustry
- EBITDA Margin
- 0.53%
- -2.52%
- FCF Margin
- -3.20%
- 0.65%
Returns on capitalIndustry
- Return on Equity (ROE)
- 102.3%
- -17.3%
- Return on Assets (ROA)
- 56.8%
- -12.3%
- Return on Invested Capital (ROIC)
- 1.69%
- -2.83%
- Return on Capital Employed (ROCE)
- 0.67%
- -8.13%
Financial positionIndustry
- Current Ratio
- 2.94
- 2.49
- Quick Ratio
- 2.08
- 1.53
- Interest Coverage
- 6.06
- -1.63
GrowthIndustry
- Revenue Growth (YoY)
- 5.73%
- 9.42%
- Net Income Growth (YoY)
- 3702.5%
- 13.4%
- FCF Growth (YoY)
- -208.0%
- 7.64%
- Revenue Growth (3Y CAGR)
- 1.50%
- 7.08%
- Revenue Growth (5Y CAGR)
- 3.99%
- 11.8%
- EPS Growth (3Y CAGR)
- 108.0%
- 3.11%
EfficiencyIndustry
- Asset Turnover
- 1.80
- 0.59
- Inventory Turnover
- 3.70
- 2.20
- Revenue Per Employee
- $318.40K
- $331.99K
- Profits Per Employee
- $100.32K
- -$46.47K
- Employee Count
- 40
- 193
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $3.07M
- $3.95M
- Net Cash Per Share
- $0.41
- $0.26
- Equity (Book Value)
- $5.93M
- $63.80M
- Book Value Per Share
- $0.80
- $3.26
- Tangible Book Value
- $5.92M
- $11.61M
- Working Capital
- $4.62M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$4.42K
- -$3.94M
- FCF Per Share
- -$0.05
- -$0.00
Taxes and interestIndustry
- Interest Expense
- $7.46K
- $5.40M
- Income Tax
- -$1.14M
- $1.55M
Scores and fair valueIndustry
- Graham Number
- $2.20
- $38.11
- Piotroski F-Score
- 5
- 5
- Beneish M-Score
- 1.15
- -2.64
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | ESMC | S&P 500 | Difference | ESMC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +14.4% | +0.6% | +13.7 pts | ||
| 3 months | -8.5% | +3.4% | −11.9 pts | ||
| Year to date | +9.0% | +13.3% | −4.3 pts | ||
| 1 year | +3.9% | +16.6% | −12.7 pts | ||
| 3 years | -36.9% | +86.4% | −123.3 pts | -14.2% | +23.1% |
| 5 years | +14.4% | +81.9% | −67.5 pts | +2.7% | +12.7% |
| 10 years | -59.3% | +318.9% | −378.2 pts | -8.6% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M ESMC shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 25.3 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 82,923 | 0.0% | 3,282 | 25.3 |
| Oct 15, 2026 | 82,923 | 0.0% | 15,525 | 5.3 |
| Sep 30, 2026 | 82,923 | 0.0% | 18,969 | 4.4 |
| Sep 15, 2026 | 82,923 | 0.0% | 15,368 | 5.4 |
| Aug 31, 2026 | 82,923 | -0.5% | 19,215 | 4.3 |
| Aug 14, 2026 | 83,317 | -0.7% | 1,790 | 46.5 |
| Jul 31, 2026 | 83,867 | +1.1% | 6,156 | 13.6 |
| Jul 15, 2026 | 82,923 | 0.0% | 11,738 | 7.1 |
| Jun 30, 2026 | 82,923 | -1.1% | 4,957 | 16.7 |
| Jun 15, 2026 | 83,822 | 0.0% | 20,146 | 4.2 |
| May 29, 2026 | 83,822 | -51.0% | 89,881 | 1.0 |
| May 15, 2026 | 171,227 | +1141413.3% | 83,991 | 2.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?